Clinical Trial Update: ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®) [Phase 3]

View source ↗

Summary

This record describes an extension study (ALK21-003EXT) designed to evaluate the long-term safety of VIVITROL (naltrexone) in patients with alcohol dependence, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Alcohol Dependence | Phase 3 | Status: COMPLETED | Results posted: 2010-12-08